$STRW
Strawberry Fields Reit Inc Stock $strw

$strw Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224019017 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$29.27M	$27.83M	$24.25M
YoY Change	20.43%	14.79%	5.61%
Cost Of Revenue	$3.446M	$3.714M	$3.718M
YoY Change	-7.29%	-0.11%	26.29%
Gross Profit	$25.83M	$24.12M	$20.53M
YoY Change	25.43%	17.49%	2.57%
Gross Profit Margin	88.23%	86.66%	84.67%
Selling, General & Admin	$2.101M	$1.544M	$1.462M
YoY Change	120.93%	5.61%	-48.52%
% of Gross Profit	8.14%	6.4%	7.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$7.020M	$7.194M	$6.231M
YoY Change	12.68%	15.45%	-14.44%
% of Gross Profit	27.18%	29.83%	30.35%
Operating Expenses	$13.97M	$13.55M	$14.76M
YoY Change	18.51%	-8.17%	43.9%
Operating Profit	$15.30M	$14.29M	$9.492M
YoY Change	22.23%	50.5%	-2.76%
Interest Expense	$8.258M	$8.293M	$5.353M
YoY Change	41.14%	54.92%	-137.21%
% of Operating Profit	53.98%	58.05%	56.39%
Other Income/Expense, Net		-$47.00K	-$19.00K
YoY Change		147.37%	-97.25%
Pretax Income	$7.040M	$5.992M	$4.139M
YoY Change	23.9%	44.77%	-177.86%
Income Tax
% Of Pretax Income
Net Earnings	$938.0K	$746.0K	$495.0K
YoY Change	34.38%	50.71%	-109.31%
Net Earnings / Revenue	3.2%	2.68%	2.04%
Basic Earnings Per Share	$0.14	$0.12	$0.08
Diluted Earnings Per Share	$0.14	$0.12	$0.08
COMMON SHARES
Basic Shares Outstanding	6.436M shares	6.474M shares	6.366M shares
Diluted Shares Outstanding	6.478M shares	6.478M shares	6.366M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.12M	$15.15M	$32.40M
YoY Change	-57.12%	-53.25%	88.15%
Cash & Equivalents	$16.12M	$15.15M	$32.40M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$25.27M	$24.30M	$24.03M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$41.39M	$39.45M	$56.42M
YoY Change	-33.16%	-30.08%	37.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$514.2M	$515.5M	$438.0M
YoY Change	19.11%	17.71%	-4.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$31.71M	$29.46M	$26.19M
YoY Change	-9.79%	12.48%	-0.6%
Total Long-Term Assets	$594.5M	$595.5M	$493.1M
YoY Change	19.92%	20.75%	-3.84%
TOTAL ASSETS
Total Short-Term Assets	$41.39M	$39.45M	$56.42M
Total Long-Term Assets	$594.5M	$595.5M	$493.1M
Total Assets	$635.9M	$634.9M	$549.6M
YoY Change	14.03%	15.53%	-0.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.65M	$11.64M	$10.88M
YoY Change	13.51%	6.98%	15.89%
Accrued Expenses	$4.267M	$4.413M	$1.755M
YoY Change	154.75%	151.45%	-11.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$20.92M	$16.05M	$12.64M
YoY Change	27.99%	27.04%	11.04%
LONG-TERM LIABILITIES
Long-Term Debt	$551.9M	$558.9M	$461.2M
YoY Change	15.31%	21.18%	-5.25%
Other Long-Term Liabilities	$12.42M	$11.73M	$9.979M
YoY Change	16.79%	17.53%	-8.06%
Total Long-Term Liabilities	$564.3M	$570.6M	$471.2M
YoY Change	15.35%	21.1%	-5.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.92M	$16.05M	$12.64M
Total Long-Term Liabilities	$564.3M	$570.6M	$471.2M
Total Liabilities	$585.2M	$586.7M	$499.4M
YoY Change	15.75%	17.47%	-9.27%
SHAREHOLDERS EQUITY
Retained Earnings	$1.304M	$1.200M	$1.403M
YoY Change	-6.92%	-14.47%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.438M	$7.490M	$7.858M
YoY Change
Total Liabilities & Shareholders Equity	$635.9M	$634.9M	$549.6M
YoY Change	14.03%	15.53%	-0.77%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$938.0K	$746.0K	$495.0K
YoY Change	34.38%	50.71%	-109.31%
Depreciation, Depletion And Amortization	$7.020M	$7.194M	$6.231M
YoY Change	12.68%	15.45%	-14.44%
Cash From Operating Activities	$20.57M	$2.125M	$9.976M
YoY Change	32.05%	-78.7%	-465.29%
INVESTING ACTIVITIES
Capital Expenditures	$5.825M	$0.00	$6.000M
YoY Change	18690.32%	-100.0%
Acquisitions	$5.830M	$5.850M
YoY Change
Other Investing Activities	$138.0K	-$17.57M	$1.477M
YoY Change	3.76%	-1289.84%	811.73%
Cash From Investing Activities	-$5.687M	-$17.57M	-$4.523M
YoY Change	-5675.49%	288.55%	-2891.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.50M	$16.42M	$1.769M
YoY Change	663.79%	828.32%	-115.56%
NET CHANGE
Cash From Operating Activities	20.57M	$2.125M	$9.976M
Cash From Investing Activities	-5.687M	-$17.57M	-$4.523M
Cash From Financing Activities	-11.50M	$16.42M	$1.769M
Net Change In Cash	3.387M	$973.0K	$7.222M
YoY Change	-76.1%	-86.53%	-151.82%
FREE CASH FLOW
Cash From Operating Activities	$20.57M	$2.125M	$9.976M
Capital Expenditures	$5.825M	$0.00	$6.000M
Free Cash Flow	$14.74M	$2.125M	$3.976M
YoY Change	-5.16%	-46.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate		usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue		usd
CY2024Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate		usd
CY2023Q1	STRW	Purchase Of Lease Rights PurchaseOfLeaseRights		usd
CY2024Q1	STRW	Purchase Of Real Estate Investments PurchaseOfRealEstateInvestments		usd
CY2023Q1	STRW	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable		usd
CY2024Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable		usd
CY2024Q1	STRW	Repayment Of Non Controlling Interest Redemption Liabilities RepaymentOfNonControllingInterestRedemptionLiabilities		usd
CY2023Q1	STRW	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable		usd
CY2024Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable		usd
CY2024Q1	STRW	Repayment Of Non Controlling Interest Redemption Liabilities RepaymentOfNonControllingInterestRedemptionLiabilities		usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41628
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-2336054
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	South Bend
CY2024Q1	dei	City Area Code CityAreaCode	(574)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	807-0800
CY2024Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.0001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	STRW
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6436128	shares
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001782430
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue		usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate		usd
CY2024Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate		usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue		usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue		usd
CY2024Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate		usd
CY2023Q1	STRW	Purchase Of Lease Rights PurchaseOfLeaseRights		usd
CY2023Q1	STRW	Purchase Of Lease Rights PurchaseOfLeaseRights		usd
CY2024Q1	STRW	Purchase Of Real Estate Investments PurchaseOfRealEstateInvestments		usd
CY2024Q1	STRW	Purchase Of Real Estate Investments PurchaseOfRealEstateInvestments		usd
CY2023Q1	STRW	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable		usd
CY2023Q1	STRW	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable		usd
CY2024Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable		usd
CY2024Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable		usd
CY2024Q1	STRW	Repayment Of Non Controlling Interest Redemption Liabilities RepaymentOfNonControllingInterestRedemptionLiabilities		usd
CY2024Q1	STRW	Repayment Of Non Controlling Interest Redemption Liabilities RepaymentOfNonControllingInterestRedemptionLiabilities		usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41628
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	South Bend
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46628
CY2024Q1	dei	City Area Code CityAreaCode	(574)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	807-0800
CY2024Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.0001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	STRW
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	us-gaap	Real Estate Investments RealEstateInvestments	511120000	usd
CY2023Q4	us-gaap	Real Estate Investments RealEstateInvestments	518314000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15145000	usd
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41628
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	Strawberry Fields REIT, Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-2336054
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6101 Nimtz Parkway
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	South Bend
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46628
CY2024Q1	dei	City Area Code CityAreaCode	(574)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	807-0800
CY2024Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.0001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	STRW
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6436128	shares
CY2024Q1	us-gaap	Real Estate Investments RealEstateInvestments	511120000	usd
CY2023Q4	us-gaap	Real Estate Investments RealEstateInvestments	518314000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15145000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	23586000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	25585000	usd
CY2024Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	24302000	usd
CY2023Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	23334000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1542000	usd
CY2024Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	25700000	usd
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	8604000	usd
CY2024Q1	us-gaap	Deferred Costs DeferredCosts	5874000	usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	6035000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	17706000	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	7500000	usd
CY2024Q1	us-gaap	Assets Assets	634920000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	11639000	usd
CY2024Q1	STRW	Bonds Bonds	125571000	usd
CY2023Q4	STRW	Bonds Bonds	100294000	usd
CY2024Q1	STRW	Notes Payable And Other Debt NotesPayableAndOtherDebt	433345000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4413000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1542000	usd
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	11728000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	14587000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	586696000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41628
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	South Bend
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46628
CY2024Q1	dei	City Area Code CityAreaCode	(574)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	807-0800
CY2024Q1	dei	Trading Symbol TradingSymbol	STRW
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6436128	shares
CY2024Q1	us-gaap	Real Estate Investments RealEstateInvestments	511120000	usd
CY2023Q4	us-gaap	Real Estate Investments RealEstateInvestments	518314000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15145000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	23586000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	25585000	usd
CY2024Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	24302000	usd
CY2023Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	23334000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1542000	usd
CY2024Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	25700000	usd
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	8604000	usd
CY2024Q1	us-gaap	Deferred Costs DeferredCosts	5874000	usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	6035000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	17706000	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	7500000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	3502000	usd
CY2024Q1	us-gaap	Assets Assets	634920000	usd
CY2023Q4	us-gaap	Assets Assets	616795000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	11639000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	16907000	usd
CY2024Q1	STRW	Bonds Bonds	125571000	usd
CY2023Q4	STRW	Bonds Bonds	100294000	usd
CY2024Q1	STRW	Notes Payable And Other Debt NotesPayableAndOtherDebt	433345000	usd
CY2023Q4	STRW	Notes Payable And Other Debt NotesPayableAndOtherDebt	436192000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4413000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1542000	usd
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	11728000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	586696000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	569522000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	23586000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	25585000	usd
CY2024Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	24302000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1542000	usd
CY2024Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	25700000	usd
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	8604000	usd
CY2024Q1	us-gaap	Deferred Costs DeferredCosts	5874000	usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	6035000	usd
CY2024Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	17280000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	17706000	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	7500000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	3502000	usd
CY2024Q1	us-gaap	Assets Assets	634920000	usd
CY2023Q4	us-gaap	Assets Assets	616795000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	11639000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	16907000	usd
CY2024Q1	STRW	Bonds Bonds	125571000	usd
CY2023Q4	STRW	Bonds Bonds	100294000	usd
CY2024Q1	STRW	Notes Payable And Other Debt NotesPayableAndOtherDebt	433345000	usd
CY2023Q4	STRW	Notes Payable And Other Debt NotesPayableAndOtherDebt	436192000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4413000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1542000	usd
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	11728000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	14587000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	569522000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6468508	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6487856	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6487856	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6468508	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6468508	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6487856	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6487856	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5593000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5746000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	697000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	529000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1200000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1232000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	7490000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	40734000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	39766000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	48224000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	27834000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24247000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	7194000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	6231000	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	904000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	757000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2451000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1544000	usd
CY2024Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	3714000	usd
CY2023Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	3718000	usd
CY2024Q1	STRW	Facility Rent Expenses FacilityRentExpenses	193000	usd
CY2023Q1	STRW	Facility Rent Expenses FacilityRentExpenses	136000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	13549000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	14285000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	4808000	usd
CY2024Q1	STRW	Mortgage Insurance Premium MortgageInsurancePremium	400000	usd
CY2023Q1	STRW	Mortgage Insurance Premium MortgageInsurancePremium	415000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	5353000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	5992000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	4139000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5246000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3644000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	746000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	495000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1350000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6468508	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6487856	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6487856	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5593000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5746000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1200000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1232000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	7490000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	40734000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	39766000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	48224000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47273000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	634920000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	616795000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	27834000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24247000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	7194000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	6231000	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	904000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	757000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2451000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1544000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1462000	usd
CY2024Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	3714000	usd
CY2023Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	3718000	usd
CY2024Q1	STRW	Facility Rent Expenses FacilityRentExpenses	193000	usd
CY2023Q1	STRW	Facility Rent Expenses FacilityRentExpenses	136000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	13549000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	14755000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	14285000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	9492000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	7732000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	4808000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	161000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	130000	usd
CY2024Q1	STRW	Mortgage Insurance Premium MortgageInsurancePremium	400000	usd
CY2023Q1	STRW	Mortgage Insurance Premium MortgageInsurancePremium	415000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	8293000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	5353000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	5992000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5746000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	529000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1232000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	7490000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	40734000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	39766000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	48224000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47273000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	634920000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	616795000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	27834000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	7194000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	6231000	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	904000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	757000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2451000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1544000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1462000	usd
CY2024Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	3714000	usd
CY2023Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	3718000	usd
CY2024Q1	STRW	Facility Rent Expenses FacilityRentExpenses	193000	usd
CY2023Q1	STRW	Facility Rent Expenses FacilityRentExpenses	136000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	13549000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	14755000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	14285000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	9492000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	7732000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	4808000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	130000	usd
CY2024Q1	STRW	Mortgage Insurance Premium MortgageInsurancePremium	400000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	8293000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	5353000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	5992000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5246000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	746000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	495000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1350000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2318000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1182000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2041000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	914000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	772000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	746000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	495000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47273000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	634920000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	616795000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	27834000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24247000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	7194000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	6231000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	757000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2451000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1544000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1462000	usd
CY2024Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	3714000	usd
CY2023Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	3718000	usd
CY2024Q1	STRW	Facility Rent Expenses FacilityRentExpenses	193000	usd
CY2023Q1	STRW	Facility Rent Expenses FacilityRentExpenses	136000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	13549000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	14285000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	9492000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	7732000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	161000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	130000	usd
CY2024Q1	STRW	Mortgage Insurance Premium MortgageInsurancePremium	400000	usd
CY2023Q1	STRW	Mortgage Insurance Premium MortgageInsurancePremium	415000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	5353000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	5992000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	4139000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5246000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3644000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	746000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	495000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1350000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2318000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1182000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2041000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	914000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	746000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	495000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6478288	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6365856	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6365856	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	49384000	usd
CY2023Q1	us-gaap	Dividends Dividends	700000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	4999000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2318000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	4139000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	50142000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47273000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47273000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	4139000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5246000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3644000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	746000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	495000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1350000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2318000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1182000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2041000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	914000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	772000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	746000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6478288	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6478288	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6365856	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6365856	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	49384000	usd
CY2023Q1	us-gaap	Dividends Dividends	700000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	4999000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2318000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	4139000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	50142000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47273000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47273000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	153000	usd
CY2024Q1	us-gaap	Dividends Dividends	778000	usd
CY2024Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	5460000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1350000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	5992000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	48224000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	48224000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	5992000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	4139000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8098000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6988000	usd
CY2024Q1	STRW	Amortization Of Bond Issuance Costs AmortizationOfBondIssuanceCosts	162000	usd
CY2023Q1	STRW	Amortization Of Bond Issuance Costs AmortizationOfBondIssuanceCosts	45000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2451000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	161000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	130000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	3998000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-21000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	146000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	78000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-805000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-449000	usd
CY2024Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	968000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8127000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3756000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2125000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2318000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1182000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2041000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	914000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	495000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6478288	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6478288	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6365856	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6365856	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	49384000	usd
CY2023Q1	us-gaap	Dividends Dividends	700000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	4999000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2318000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	4139000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	50142000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47273000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	153000	usd
CY2024Q1	us-gaap	Dividends Dividends	778000	usd
CY2024Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	5460000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1350000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	5992000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	48224000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	5992000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	4139000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8098000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6988000	usd
CY2024Q1	STRW	Amortization Of Bond Issuance Costs AmortizationOfBondIssuanceCosts	162000	usd
CY2023Q1	STRW	Amortization Of Bond Issuance Costs AmortizationOfBondIssuanceCosts	45000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2451000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	161000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	130000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	3998000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-21000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	146000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	78000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-805000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-449000	usd
CY2024Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	968000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	491000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8127000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3756000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-78000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2125000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9976000	usd
CY2024Q1	STRW	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable	-426000	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	1477000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17574000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4523000	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6478288	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6478288	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6365856	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6365856	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	49384000	usd
CY2023Q1	us-gaap	Dividends Dividends	700000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	4999000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2318000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	4139000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47273000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47273000	usd
CY2024Q1	us-gaap	Dividends Dividends	778000	usd
CY2024Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	5460000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1350000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	5992000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	48224000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	48224000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	5992000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	4139000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6988000	usd
CY2024Q1	STRW	Amortization Of Bond Issuance Costs AmortizationOfBondIssuanceCosts	162000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2451000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	161000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	130000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	3998000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-21000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	78000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-805000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-449000	usd
CY2024Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	968000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	491000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8127000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3756000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-146000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9976000	usd
CY2024Q1	STRW	Purchase Of Lease Rights PurchaseOfLeaseRights	-18000000	usd
CY2023Q1	STRW	Purchase Of Real Estate Investments PurchaseOfRealEstateInvestments	-6000000	usd
CY2024Q1	STRW	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable	-426000	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	1477000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17574000	usd
CY2024Q1	STRW	Proceeds From Issuance Of Bonds ProceedsFromIssuanceOfBonds	25660000	usd
CY2023Q1	STRW	Proceeds From Issuance Of Bonds ProceedsFromIssuanceOfBonds	10389000	usd
CY2024Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	2847000	usd
CY2023Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	2761000	usd
CY2023Q1	STRW	Repayment Of Non Controlling Interest Redemption Liabilities RepaymentOfNonControllingInterestRedemptionLiabilities	160000	usd
CY2024Q1	STRW	Payment Of Dividends PaymentOfDividends	778000	usd
CY2023Q1	STRW	Payment Of Dividends PaymentOfDividends	700000	usd
CY2023Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	4999000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	153000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16422000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	153000	usd
CY2024Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	5460000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1350000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	5992000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	48224000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	48224000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	5992000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	4139000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6988000	usd
CY2024Q1	STRW	Amortization Of Bond Issuance Costs AmortizationOfBondIssuanceCosts	162000	usd
CY2023Q1	STRW	Amortization Of Bond Issuance Costs AmortizationOfBondIssuanceCosts	45000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2451000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	130000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	3998000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-21000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	146000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	78000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-805000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-449000	usd
CY2024Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	968000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	491000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8127000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3756000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-146000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-78000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2125000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9976000	usd
CY2024Q1	STRW	Purchase Of Lease Rights PurchaseOfLeaseRights	-18000000	usd
CY2023Q1	STRW	Purchase Of Real Estate Investments PurchaseOfRealEstateInvestments	-6000000	usd
CY2024Q1	STRW	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable	-426000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17574000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4523000	usd
CY2024Q1	STRW	Proceeds From Issuance Of Bonds ProceedsFromIssuanceOfBonds	25660000	usd
CY2024Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	2847000	usd
CY2023Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	2761000	usd
CY2023Q1	STRW	Repayment Of Non Controlling Interest Redemption Liabilities RepaymentOfNonControllingInterestRedemptionLiabilities	160000	usd
CY2024Q1	STRW	Payment Of Dividends PaymentOfDividends	778000	usd
CY2023Q1	STRW	Payment Of Dividends PaymentOfDividends	700000	usd
CY2024Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	5460000	usd
CY2023Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	4999000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	153000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16422000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1769000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	973000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7222000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	37758000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	45704000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	38731000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	52926000	usd
CY2024Q1	STRW	Foreign Currency Translation Adjustments ForeignCurrencyTranslationAdjustments	1350000	usd
CY2023Q1	STRW	Foreign Currency Translation Adjustments ForeignCurrencyTranslationAdjustments	2318000	usd
CY2024Q1	STRW	Proceeds From Issuance Of Bonds ProceedsFromIssuanceOfBonds	25660000	usd
CY2023Q1	STRW	Proceeds From Issuance Of Bonds ProceedsFromIssuanceOfBonds	10389000	usd
CY2024Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	2847000	usd
CY2023Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	2761000	usd
CY2023Q1	STRW	Repayment Of Non Controlling Interest Redemption Liabilities RepaymentOfNonControllingInterestRedemptionLiabilities	160000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9976000	usd
CY2024Q1	STRW	Purchase Of Lease Rights PurchaseOfLeaseRights	-18000000	usd
CY2023Q1	STRW	Purchase Of Real Estate Investments PurchaseOfRealEstateInvestments	-6000000	usd
CY2024Q1	STRW	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable	-426000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17574000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4523000	usd
CY2024Q1	STRW	Proceeds From Issuance Of Bonds ProceedsFromIssuanceOfBonds	25660000	usd
CY2023Q1	STRW	Proceeds From Issuance Of Bonds ProceedsFromIssuanceOfBonds	10389000	usd
CY2024Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	2847000	usd
CY2023Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	2761000	usd
CY2023Q1	STRW	Repayment Of Non Controlling Interest Redemption Liabilities RepaymentOfNonControllingInterestRedemptionLiabilities	160000	usd
CY2024Q1	STRW	Payment Of Dividends PaymentOfDividends	778000	usd
CY2023Q1	STRW	Payment Of Dividends PaymentOfDividends	700000	usd
CY2024Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	5460000	usd
CY2023Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	4999000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	153000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16422000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1769000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	973000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7222000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	45704000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	38731000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	52926000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	9620000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	6078000	usd
CY2024Q1	STRW	Foreign Currency Translation Adjustments ForeignCurrencyTranslationAdjustments	1350000	usd
CY2023Q1	STRW	Foreign Currency Translation Adjustments ForeignCurrencyTranslationAdjustments	2318000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3017000	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80A_eus-gaap--NatureOfOperations_zb19udLFVWj1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1. <span id="xdx_821_zmout8MeTFPd">Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Overview</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The Company</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">STRAWBERRY FIELDS REIT, Inc. (the “Company”) is a Maryland corporation formed in July 2019. The Company commenced operations on June 8, 2021. The Company conducts its business through a traditional UPREIT structure in which substantially all of its assets are owned by subsidiaries of Strawberry Fields Realty, LP, a Delaware limited partnership formed in July 2019 (the “Operating Partnership”). The Company is the general partner of the Operating Partnership (“OP”). The Company owns approximately <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--StrawberryFieldsRealtyLPMember__us-gaap--AwardTypeAxis__custom--OperatingPartnershipMember_zd5RmfJBc8Oc" title="Equity method investment ownership percentage"><span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--StrawberryFieldsRealtyLPMember__us-gaap--AwardTypeAxis__custom--OperatingPartnershipMember_z0FlMZjjSWle" title="Equity method investment ownership percentage">12.6</span></span>% of the outstanding OP units as of March 31, 2024 and December 31, 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the sole general partner of the Operating Partnership, the Company has the exclusive power under the partnership agreement to manage and conduct the business affairs of the Operating Partnership, subject to certain limited approval and voting rights of the limited partners. The Company may cause the Operating Partnership to issue additional OP units in connection with property acquisitions, compensation or otherwise. The Company became a publicly traded entity on September 21, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is engaged in the ownership, acquisition, financing and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties. The Company’s portfolio consists of 100 healthcare properties with an aggregate of 12,449 licensed beds. The Company holds fee title to 97 of these properties and holds three properties under long-term leases. These properties are located in Arkansas, Illinois, Indiana, Kentucky, Michigan, Ohio, Oklahoma, Tennessee and Texas. The Company generates substantially all of its revenues by leasing its properties to tenants under long-term leases primarily on a triple-net basis, under which the tenant pays the cost of real estate taxes, insurance and other operating costs of the facility and capital expenditures. Each healthcare facility located at its properties is managed by a qualified operator with an experienced management team.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interim Condensed Consolidated Financial Statements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited, condensed consolidated financial statements of the Company have been prepared in accordance with GAAP for interim financial information, and the Securities and Exchange Commission (“SEC”) rules for interim financial reporting. Certain information and footnote disclosures normally included in the Condensed Consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. However, in the opinion of management, the accompanying interim Condensed Consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the Company’s Condensed Consolidated financial position as of March 31, 2024, and the Condensed Consolidated results of operations and cash flows for the periods presented. The Condensed Consolidated results of operations for interim periods are not necessarily indicative of the results of operations to be expected for any subsequent interim period or for the fiscal year ending December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Variable Interest Entity</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company consolidates the Operating Partnership, a variable interest entity (“VIE”) in which the Company is considered the primary beneficiary. The primary beneficiary is the entity that has (i) the power to direct the activities that most significantly impact the entity’s economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could be significant to the VIE.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Non-Controlling Interest</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A non-controlling interest is defined as the portion of the equity in an entity not attributable, directly or indirectly, to the primary beneficiary. Non-controlling interests are required to be presented as a separate component of equity on a Condensed Consolidated balance sheet. Accordingly, the presentation of net income is modified to present the income attributed to controlling and non-controlling interests. The non-controlling interest on the Company’s Condensed Consolidated balance sheets represents OP units not held by the Company and represents approximately <span id="xdx_903_ecustom--NonControllingInterestOperatiingPercentage_pid_dp_uPure_c20240101__20240331_ztUB2aE8Bjje" title="Non-controlling interest operatiing percentage."><span id="xdx_902_ecustom--NonControllingInterestOperatiingPercentage_pid_dp_uPure_c20230101__20231231_zuHOqOs4d8wj" title="Non-controlling interest operatiing percentage.">87.4</span></span>% of the outstanding OP Units issued by the Operating Partnership as of March 31, 2024 and December 31, 2023, respectively. OP Units are exchangeable 1 to 1 with shares of common stock. The holders of these OP units are entitled to share in cash distributions from the Operating Partnership in proportion to their percentage ownership of OP units. Net income is allocated to the non-controlling interest based on the weighted average of OP units outstanding during the period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis of Presentation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its accounting records on an accrual basis in accordance with generally accepted accounting principles in the United States of America (“GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STRAWBERRY FIELDS REIT, INC. and SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	STRW	Non Controlling Interest Operatiing Percentage NonControllingInterestOperatiingPercentage	0.874	pure
CY2024Q1	us-gaap	Cash Cash	24700000	usd
CY2023Q4	us-gaap	Cash Cash	22700000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3017000	usd
CY2023	STRW	Non Controlling Interest Operatiing Percentage NonControllingInterestOperatiingPercentage	0.874	pure
CY2023Q4	STRW	Acquisition Of Lease Rights AcquisitionOfLeaseRights	18000000	usd
CY2023Q1	STRW	Payment Of Dividends PaymentOfDividends	700000	usd
CY2024Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	5460000	usd
CY2023Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	4999000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	153000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16422000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1769000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	973000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7222000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	37758000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	45704000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	38731000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	52926000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	9620000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	6078000	usd
CY2024Q1	STRW	Foreign Currency Translation Adjustments ForeignCurrencyTranslationAdjustments	1350000	usd
CY2023Q1	STRW	Foreign Currency Translation Adjustments ForeignCurrencyTranslationAdjustments	2318000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3017000	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80A_eus-gaap--NatureOfOperations_zb19udLFVWj1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1. <span id="xdx_821_zmout8MeTFPd">Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Overview</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The Company</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">STRAWBERRY FIELDS REIT, Inc. (the “Company”) is a Maryland corporation formed in July 2019. The Company commenced operations on June 8, 2021. The Company conducts its business through a traditional UPREIT structure in which substantially all of its assets are owned by subsidiaries of Strawberry Fields Realty, LP, a Delaware limited partnership formed in July 2019 (the “Operating Partnership”). The Company is the general partner of the Operating Partnership (“OP”). The Company owns approximately <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--StrawberryFieldsRealtyLPMember__us-gaap--AwardTypeAxis__custom--OperatingPartnershipMember_zd5RmfJBc8Oc" title="Equity method investment ownership percentage"><span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--StrawberryFieldsRealtyLPMember__us-gaap--AwardTypeAxis__custom--OperatingPartnershipMember_z0FlMZjjSWle" title="Equity method investment ownership percentage">12.6</span></span>% of the outstanding OP units as of March 31, 2024 and December 31, 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the sole general partner of the Operating Partnership, the Company has the exclusive power under the partnership agreement to manage and conduct the business affairs of the Operating Partnership, subject to certain limited approval and voting rights of the limited partners. The Company may cause the Operating Partnership to issue additional OP units in connection with property acquisitions, compensation or otherwise. The Company became a publicly traded entity on September 21, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is engaged in the ownership, acquisition, financing and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties. The Company’s portfolio consists of 100 healthcare properties with an aggregate of 12,449 licensed beds. The Company holds fee title to 97 of these properties and holds three properties under long-term leases. These properties are located in Arkansas, Illinois, Indiana, Kentucky, Michigan, Ohio, Oklahoma, Tennessee and Texas. The Company generates substantially all of its revenues by leasing its properties to tenants under long-term leases primarily on a triple-net basis, under which the tenant pays the cost of real estate taxes, insurance and other operating costs of the facility and capital expenditures. Each healthcare facility located at its properties is managed by a qualified operator with an experienced management team.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interim Condensed Consolidated Financial Statements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited, condensed consolidated financial statements of the Company have been prepared in accordance with GAAP for interim financial information, and the Securities and Exchange Commission (“SEC”) rules for interim financial reporting. Certain information and footnote disclosures normally included in the Condensed Consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. However, in the opinion of management, the accompanying interim Condensed Consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the Company’s Condensed Consolidated financial position as of March 31, 2024, and the Condensed Consolidated results of operations and cash flows for the periods presented. The Condensed Consolidated results of operations for interim periods are not necessarily indicative of the results of operations to be expected for any subsequent interim period or for the fiscal year ending December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Variable Interest Entity</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company consolidates the Operating Partnership, a variable interest entity (“VIE”) in which the Company is considered the primary beneficiary. The primary beneficiary is the entity that has (i) the power to direct the activities that most significantly impact the entity’s economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could be significant to the VIE.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Non-Controlling Interest</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A non-controlling interest is defined as the portion of the equity in an entity not attributable, directly or indirectly, to the primary beneficiary. Non-controlling interests are required to be presented as a separate component of equity on a Condensed Consolidated balance sheet. Accordingly, the presentation of net income is modified to present the income attributed to controlling and non-controlling interests. The non-controlling interest on the Company’s Condensed Consolidated balance sheets represents OP units not held by the Company and represents approximately <span id="xdx_903_ecustom--NonControllingInterestOperatiingPercentage_pid_dp_uPure_c20240101__20240331_ztUB2aE8Bjje" title="Non-controlling interest operatiing percentage."><span id="xdx_902_ecustom--NonControllingInterestOperatiingPercentage_pid_dp_uPure_c20230101__20231231_zuHOqOs4d8wj" title="Non-controlling interest operatiing percentage.">87.4</span></span>% of the outstanding OP Units issued by the Operating Partnership as of March 31, 2024 and December 31, 2023, respectively. OP Units are exchangeable 1 to 1 with shares of common stock. The holders of these OP units are entitled to share in cash distributions from the Operating Partnership in proportion to their percentage ownership of OP units. Net income is allocated to the non-controlling interest based on the weighted average of OP units outstanding during the period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis of Presentation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its accounting records on an accrual basis in accordance with generally accepted accounting principles in the United States of America (“GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STRAWBERRY FIELDS REIT, INC. and SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	STRW	Non Controlling Interest Operatiing Percentage NonControllingInterestOperatiingPercentage	0.874	pure
CY2023	STRW	Non Controlling Interest Operatiing Percentage NonControllingInterestOperatiingPercentage	0.874	pure
CY2024Q1	us-gaap	Cash Cash	24700000	usd
CY2023Q4	us-gaap	Cash Cash	22700000	usd
CY2023Q4	STRW	Acquisition Of Lease Rights AcquisitionOfLeaseRights	18000000	usd
CY2023Q4	STRW	Other Finite Lived Intangible Assets Amortization OtherFiniteLivedIntangibleAssetsAmortization	-904000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1769000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	973000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7222000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	45704000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	38731000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	52926000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	9620000	usd
CY2023Q1	STRW	Foreign Currency Translation Adjustments ForeignCurrencyTranslationAdjustments	2318000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3017000	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80A_eus-gaap--NatureOfOperations_zb19udLFVWj1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1. <span id="xdx_821_zmout8MeTFPd">Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Overview</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The Company</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">STRAWBERRY FIELDS REIT, Inc. (the “Company”) is a Maryland corporation formed in July 2019. The Company commenced operations on June 8, 2021. The Company conducts its business through a traditional UPREIT structure in which substantially all of its assets are owned by subsidiaries of Strawberry Fields Realty, LP, a Delaware limited partnership formed in July 2019 (the “Operating Partnership”). The Company is the general partner of the Operating Partnership (“OP”). The Company owns approximately <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--StrawberryFieldsRealtyLPMember__us-gaap--AwardTypeAxis__custom--OperatingPartnershipMember_zd5RmfJBc8Oc" title="Equity method investment ownership percentage"><span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--StrawberryFieldsRealtyLPMember__us-gaap--AwardTypeAxis__custom--OperatingPartnershipMember_z0FlMZjjSWle" title="Equity method investment ownership percentage">12.6</span></span>% of the outstanding OP units as of March 31, 2024 and December 31, 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the sole general partner of the Operating Partnership, the Company has the exclusive power under the partnership agreement to manage and conduct the business affairs of the Operating Partnership, subject to certain limited approval and voting rights of the limited partners. The Company may cause the Operating Partnership to issue additional OP units in connection with property acquisitions, compensation or otherwise. The Company became a publicly traded entity on September 21, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is engaged in the ownership, acquisition, financing and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties. The Company’s portfolio consists of 100 healthcare properties with an aggregate of 12,449 licensed beds. The Company holds fee title to 97 of these properties and holds three properties under long-term leases. These properties are located in Arkansas, Illinois, Indiana, Kentucky, Michigan, Ohio, Oklahoma, Tennessee and Texas. The Company generates substantially all of its revenues by leasing its properties to tenants under long-term leases primarily on a triple-net basis, under which the tenant pays the cost of real estate taxes, insurance and other operating costs of the facility and capital expenditures. Each healthcare facility located at its properties is managed by a qualified operator with an experienced management team.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interim Condensed Consolidated Financial Statements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited, condensed consolidated financial statements of the Company have been prepared in accordance with GAAP for interim financial information, and the Securities and Exchange Commission (“SEC”) rules for interim financial reporting. Certain information and footnote disclosures normally included in the Condensed Consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. However, in the opinion of management, the accompanying interim Condensed Consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the Company’s Condensed Consolidated financial position as of March 31, 2024, and the Condensed Consolidated results of operations and cash flows for the periods presented. The Condensed Consolidated results of operations for interim periods are not necessarily indicative of the results of operations to be expected for any subsequent interim period or for the fiscal year ending December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Variable Interest Entity</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company consolidates the Operating Partnership, a variable interest entity (“VIE”) in which the Company is considered the primary beneficiary. The primary beneficiary is the entity that has (i) the power to direct the activities that most significantly impact the entity’s economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could be significant to the VIE.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Non-Controlling Interest</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A non-controlling interest is defined as the portion of the equity in an entity not attributable, directly or indirectly, to the primary beneficiary. Non-controlling interests are required to be presented as a separate component of equity on a Condensed Consolidated balance sheet. Accordingly, the presentation of net income is modified to present the income attributed to controlling and non-controlling interests. The non-controlling interest on the Company’s Condensed Consolidated balance sheets represents OP units not held by the Company and represents approximately <span id="xdx_903_ecustom--NonControllingInterestOperatiingPercentage_pid_dp_uPure_c20240101__20240331_ztUB2aE8Bjje" title="Non-controlling interest operatiing percentage."><span id="xdx_902_ecustom--NonControllingInterestOperatiingPercentage_pid_dp_uPure_c20230101__20231231_zuHOqOs4d8wj" title="Non-controlling interest operatiing percentage.">87.4</span></span>% of the outstanding OP Units issued by the Operating Partnership as of March 31, 2024 and December 31, 2023, respectively. OP Units are exchangeable 1 to 1 with shares of common stock. The holders of these OP units are entitled to share in cash distributions from the Operating Partnership in proportion to their percentage ownership of OP units. Net income is allocated to the non-controlling interest based on the weighted average of OP units outstanding during the period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis of Presentation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its accounting records on an accrual basis in accordance with generally accepted accounting principles in the United States of America (“GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STRAWBERRY FIELDS REIT, INC. and SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	STRW	Non Controlling Interest Operatiing Percentage NonControllingInterestOperatiingPercentage	0.874	pure
CY2024Q1	us-gaap	Cash Cash	24700000	usd
CY2023Q4	us-gaap	Cash Cash	22700000	usd
CY2023Q4	STRW	Other Finite Lived Intangible Assets Amortization OtherFiniteLivedIntangibleAssetsAmortization	-904000	usd
CY2024Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	73900000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_z4C14c0X8RH" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zrqrYxYmu1Sa">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management is required to make estimates and assumptions in the preparation of the Condensed Consolidated financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from management’s estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Cash Cash	24700000	usd
CY2023Q4	us-gaap	Cash Cash	22700000	usd
CY2024Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	73900000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-48200000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-48200000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zCVBCIGzl7sh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zlPRpoq9lK17">Concentrations of Credit Risk</span> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash and cash equivalents, notes receivable and operating leases on owned properties. These financial instruments are subject to the possibility of loss of carrying value as a result of the failure of other parties to perform according to their contractual obligations or changes in market prices which may make the instrument less valuable. Cash and cash equivalents, restricted cash and equivalents are held with various financial institutions. From time to time, these balances exceed the federally insured limits. These balances are maintained with high quality financial institutions which management believes limits the risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With respect to notes receivable, the Company obtains various collateral and other protective rights, and continually monitors these rights, in order to reduce such possibilities of loss. In addition, the Company provides reserves for potential losses based upon management’s periodic review of our portfolio.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2024, the Company held four notes receivable with an outstanding balance of $<span id="xdx_904_eus-gaap--ReceivablesNetCurrent_iI_pn5n6_c20240331_zEXPVKfpHDn2">17.3</span> million. The notes have maturities ranging from 2024 through 2046, and interest rates ranging from <span id="xdx_905_eus-gaap--LoansReceivableBasisSpreadOnVariableRate_iI_pid_dp_c20240331__srt--RangeAxis__srt--MinimumMember_zorN7lykHha" title="Receivables rate of interest">2</span>% to <span id="xdx_907_eus-gaap--LoansReceivableBasisSpreadOnVariableRate_iI_pid_dp_c20240331__srt--RangeAxis__srt--MaximumMember_zp3vBl3eWU14" title="Receivables rate of interest">11.50</span>%. One of the notes is collateralized by tenants’ accounts receivable. All other notes receivable are uncollateralized as of March 31, 2024. As of December 31, 2023, the Company held four notes receivable for a total amount of $<span id="xdx_908_eus-gaap--ReceivablesNetCurrent_iI_pn5n6_c20231231_zUqrJ1SspF1j">17.7</span> million. As of March 31, 2024, all of these notes are paid monthly and are current.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	17300000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	17700000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	511120000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	518314000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5850000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zCVBCIGzl7sh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zlPRpoq9lK17">Concentrations of Credit Risk</span> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash and cash equivalents, notes receivable and operating leases on owned properties. These financial instruments are subject to the possibility of loss of carrying value as a result of the failure of other parties to perform according to their contractual obligations or changes in market prices which may make the instrument less valuable. Cash and cash equivalents, restricted cash and equivalents are held with various financial institutions. From time to time, these balances exceed the federally insured limits. These balances are maintained with high quality financial institutions which management believes limits the risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With respect to notes receivable, the Company obtains various collateral and other protective rights, and continually monitors these rights, in order to reduce such possibilities of loss. In addition, the Company provides reserves for potential losses based upon management’s periodic review of our portfolio.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2024, the Company held four notes receivable with an outstanding balance of $<span id="xdx_904_eus-gaap--ReceivablesNetCurrent_iI_pn5n6_c20240331_zEXPVKfpHDn2">17.3</span> million. The notes have maturities ranging from 2024 through 2046, and interest rates ranging from <span id="xdx_905_eus-gaap--LoansReceivableBasisSpreadOnVariableRate_iI_pid_dp_c20240331__srt--RangeAxis__srt--MinimumMember_zorN7lykHha" title="Receivables rate of interest">2</span>% to <span id="xdx_907_eus-gaap--LoansReceivableBasisSpreadOnVariableRate_iI_pid_dp_c20240331__srt--RangeAxis__srt--MaximumMember_zp3vBl3eWU14" title="Receivables rate of interest">11.50</span>%. One of the notes is collateralized by tenants’ accounts receivable. All other notes receivable are uncollateralized as of March 31, 2024. As of December 31, 2023, the Company held four notes receivable for a total amount of $<span id="xdx_908_eus-gaap--ReceivablesNetCurrent_iI_pn5n6_c20231231_zUqrJ1SspF1j">17.7</span> million. As of March 31, 2024, all of these notes are paid monthly and are current.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	17300000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	17700000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2500000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zCVBCIGzl7sh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zlPRpoq9lK17">Concentrations of Credit Risk</span> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash and cash equivalents, notes receivable and operating leases on owned properties. These financial instruments are subject to the possibility of loss of carrying value as a result of the failure of other parties to perform according to their contractual obligations or changes in market prices which may make the instrument less valuable. Cash and cash equivalents, restricted cash and equivalents are held with various financial institutions. From time to time, these balances exceed the federally insured limits. These balances are maintained with high quality financial institutions which management believes limits the risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With respect to notes receivable, the Company obtains various collateral and other protective rights, and continually monitors these rights, in order to reduce such possibilities of loss. In addition, the Company provides reserves for potential losses based upon management’s periodic review of our portfolio.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2024, the Company held four notes receivable with an outstanding balance of $<span id="xdx_904_eus-gaap--ReceivablesNetCurrent_iI_pn5n6_c20240331_zEXPVKfpHDn2">17.3</span> million. The notes have maturities ranging from 2024 through 2046, and interest rates ranging from <span id="xdx_905_eus-gaap--LoansReceivableBasisSpreadOnVariableRate_iI_pid_dp_c20240331__srt--RangeAxis__srt--MinimumMember_zorN7lykHha" title="Receivables rate of interest">2</span>% to <span id="xdx_907_eus-gaap--LoansReceivableBasisSpreadOnVariableRate_iI_pid_dp_c20240331__srt--RangeAxis__srt--MaximumMember_zp3vBl3eWU14" title="Receivables rate of interest">11.50</span>%. One of the notes is collateralized by tenants’ accounts receivable. All other notes receivable are uncollateralized as of March 31, 2024. As of December 31, 2023, the Company held four notes receivable for a total amount of $<span id="xdx_908_eus-gaap--ReceivablesNetCurrent_iI_pn5n6_c20231231_zUqrJ1SspF1j">17.7</span> million. As of March 31, 2024, all of these notes are paid monthly and are current.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	17300000	usd
CY2024Q1	STRW	Market Concentration Risk Description MarketConcentrationRiskDescription	As of March 31, 2024 and December 31, 2023, the Company owned 97 properties and leased three and one property, respectively. The facilities are located in 9 states, with 20 facilities of its total facilities located in Illinois (which include 4,226 skilled nursing beds or 33.9% of the Company’s total beds) and 39 of its total facilities in Indiana (which include 3,240 skilled nursing beds or 26.0% of the Company’s total beds). Since tenant revenue is primarily generated from Medicare and Medicaid, the operations of the Company are indirectly subject to the administrative directives, rules and regulations of federal and state regulatory agencies, including, but not limited to the Centers for Medicare & Medicaid Services, and the Department of Health and Aging in all states in which the Company operates.
CY2022Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	55900000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-44268000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zCVBCIGzl7sh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zlPRpoq9lK17">Concentrations of Credit Risk</span> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash and cash equivalents, notes receivable and operating leases on owned properties. These financial instruments are subject to the possibility of loss of carrying value as a result of the failure of other parties to perform according to their contractual obligations or changes in market prices which may make the instrument less valuable. Cash and cash equivalents, restricted cash and equivalents are held with various financial institutions. From time to time, these balances exceed the federally insured limits. These balances are maintained with high quality financial institutions which management believes limits the risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With respect to notes receivable, the Company obtains various collateral and other protective rights, and continually monitors these rights, in order to reduce such possibilities of loss. In addition, the Company provides reserves for potential losses based upon management’s periodic review of our portfolio.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2024, the Company held four notes receivable with an outstanding balance of $<span id="xdx_904_eus-gaap--ReceivablesNetCurrent_iI_pn5n6_c20240331_zEXPVKfpHDn2">17.3</span> million. The notes have maturities ranging from 2024 through 2046, and interest rates ranging from <span id="xdx_905_eus-gaap--LoansReceivableBasisSpreadOnVariableRate_iI_pid_dp_c20240331__srt--RangeAxis__srt--MinimumMember_zorN7lykHha" title="Receivables rate of interest">2</span>% to <span id="xdx_907_eus-gaap--LoansReceivableBasisSpreadOnVariableRate_iI_pid_dp_c20240331__srt--RangeAxis__srt--MaximumMember_zp3vBl3eWU14" title="Receivables rate of interest">11.50</span>%. One of the notes is collateralized by tenants’ accounts receivable. All other notes receivable are uncollateralized as of March 31, 2024. As of December 31, 2023, the Company held four notes receivable for a total amount of $<span id="xdx_908_eus-gaap--ReceivablesNetCurrent_iI_pn5n6_c20231231_zUqrJ1SspF1j">17.7</span> million. As of March 31, 2024, all of these notes are paid monthly and are current.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	17300000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	17700000	usd
CY2024Q1	STRW	Market Concentration Risk Description MarketConcentrationRiskDescription	As of March 31, 2024 and December 31, 2023, the Company owned 97 properties and leased three and one property, respectively. The facilities are located in 9 states, with 20 facilities of its total facilities located in Illinois (which include 4,226 skilled nursing beds or 33.9% of the Company’s total beds) and 39 of its total facilities in Indiana (which include 3,240 skilled nursing beds or 26.0% of the Company’s total beds). Since tenant revenue is primarily generated from Medicare and Medicaid, the operations of the Company are indirectly subject to the administrative directives, rules and regulations of federal and state regulatory agencies, including, but not limited to the Centers for Medicare & Medicaid Services, and the Department of Health and Aging in all states in which the Company operates.
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11632000	usd
CY2022Q4	STRW	Other Finite Lived Intangible Assets Amortization OtherFiniteLivedIntangibleAssetsAmortization	-757000	usd
CY2023Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	55900000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-45025000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10875000	usd
CY2024Q1	STRW	Market Concentration Risk Description MarketConcentrationRiskDescription	As of March 31, 2024 and December 31, 2023, the Company owned 97 properties and leased three and one property, respectively. The facilities are located in 9 states, with 20 facilities of its total facilities located in Illinois (which include 4,226 skilled nursing beds or 33.9% of the Company’s total beds) and 39 of its total facilities in Indiana (which include 3,240 skilled nursing beds or 26.0% of the Company’s total beds). Since tenant revenue is primarily generated from Medicare and Medicaid, the operations of the Company are indirectly subject to the administrative directives, rules and regulations of federal and state regulatory agencies, including, but not limited to the Centers for Medicare & Medicaid Services, and the Department of Health and Aging in all states in which the Company operates.
CY2024Q1	STRW	Market Concentration Risk Description MarketConcentrationRiskDescription	As of March 31, 2024 and December 31, 2023, the Company owned 97 properties and leased three and one property, respectively. The facilities are located in 9 states, with 20 facilities of its total facilities located in Illinois (which include 4,226 skilled nursing beds or 33.9% of the Company’s total beds) and 39 of its total facilities in Indiana (which include 3,240 skilled nursing beds or 26.0% of the Company’s total beds). Since tenant revenue is primarily generated from Medicare and Medicaid, the operations of the Company are indirectly subject to the administrative directives, rules and regulations of federal and state regulatory agencies, including, but not limited to the Centers for Medicare & Medicaid Services, and the Department of Health and Aging in all states in which the Company operates.
CY2023Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	55900000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-45025000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10875000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	23586000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	25585000	usd
CY2023Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	55900000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-47296000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8604000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	23586000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	25585000	usd
CY2023Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	55900000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-47296000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8604000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	23586000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	25585000	usd
CY2024Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	737712000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	737712000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	226592000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	219398000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	23586000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	25585000	usd
CY2024Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	737712000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	737712000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	226592000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	219398000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	511120000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	518314000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5850000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2500000	usd
CY2022Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	55900000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-44268000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11632000	usd
CY2022Q4	STRW	Other Finite Lived Intangible Assets Amortization OtherFiniteLivedIntangibleAssetsAmortization	-757000	usd
CY2024Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	737712000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	737712000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	226592000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	219398000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	511120000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	518314000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5850000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2500000	usd
CY2022Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	55900000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-44268000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11632000	usd
CY2022Q4	STRW	Other Finite Lived Intangible Assets Amortization OtherFiniteLivedIntangibleAssetsAmortization	-757000	usd
CY2023Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	55900000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-45025000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10875000	usd
CY2023Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	55900000	usd
CY2023Q4	STRW	Acquisition Of Lease Rights AcquisitionOfLeaseRights	18000000	usd
CY2023Q4	STRW	Other Finite Lived Intangible Assets Amortization OtherFiniteLivedIntangibleAssetsAmortization	-904000	usd
CY2024Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	73900000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-48200000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	25700000	usd
CY2024Q1	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	109	integer
CY2024Q1	STRW	Cumulative Number Of Properties CumulativeNumberOfProperties	100	integer
CY2023Q4	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	107	integer
CY2023Q4	STRW	Cumulative Number Of Properties CumulativeNumberOfProperties	98	integer
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	192000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	99000	usd
CY2024Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	737712000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	737712000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	226592000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	219398000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	511120000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	518314000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5850000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2500000	usd
CY2022Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	55900000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-44268000	usd
CY2022Q4	STRW	Other Finite Lived Intangible Assets Amortization OtherFiniteLivedIntangibleAssetsAmortization	-757000	usd
CY2023Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	55900000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-45025000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10875000	usd
CY2023Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	55900000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-47296000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8604000	usd
CY2023Q4	STRW	Acquisition Of Lease Rights AcquisitionOfLeaseRights	18000000	usd
CY2023Q4	STRW	Other Finite Lived Intangible Assets Amortization OtherFiniteLivedIntangibleAssetsAmortization	-904000	usd
CY2024Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	73900000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-48200000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	25700000	usd
CY2024Q1	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	109	integer
CY2024Q1	STRW	Cumulative Number Of Properties CumulativeNumberOfProperties	100	integer
CY2023Q4	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	107	integer
CY2023Q4	STRW	Cumulative Number Of Properties CumulativeNumberOfProperties	98	integer
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	25700000	usd
CY2024Q1	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	109	integer
CY2024Q1	STRW	Cumulative Number Of Properties CumulativeNumberOfProperties	100	integer
CY2023Q4	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	107	integer
CY2023Q4	STRW	Cumulative Number Of Properties CumulativeNumberOfProperties	98	integer
CY2024Q1	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	109	integer
CY2023Q4	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	107	integer
CY2023Q4	STRW	Cumulative Number Of Properties CumulativeNumberOfProperties	98	integer
CY2024Q1	STRW	Cumulative Number Of Operational Beds CumulativeNumberOfOperationalBeds	12449	integer
CY2023Q4	STRW	Cumulative Number Of Operational Beds CumulativeNumberOfOperationalBeds	12201	integer
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	74070000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	89445000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	70893000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	71641000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	67945000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	229340000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4413000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1542000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4413000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1542000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y1M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	25700000	usd
CY2024Q1	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	109	integer
CY2024Q1	STRW	Cumulative Number Of Properties CumulativeNumberOfProperties	100	integer
CY2023Q4	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	107	integer
CY2023Q4	STRW	Cumulative Number Of Properties CumulativeNumberOfProperties	98	integer
CY2024Q1	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	109	integer
CY2024Q1	STRW	Cumulative Number Of Properties CumulativeNumberOfProperties	100	integer
CY2023Q4	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	107	integer
CY2023Q4	STRW	Cumulative Number Of Properties CumulativeNumberOfProperties	98	integer
CY2024Q1	STRW	Cumulative Number Of Operational Beds CumulativeNumberOfOperationalBeds	12449	integer
CY2023Q4	STRW	Cumulative Number Of Operational Beds CumulativeNumberOfOperationalBeds	12201	integer
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	74070000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	89445000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	70893000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	71641000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	67945000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	229340000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041	pure
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	21404000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	124795000	usd
CY2024Q1	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	109	integer
CY2024Q1	STRW	Cumulative Number Of Properties CumulativeNumberOfProperties	100	integer
CY2023Q4	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	107	integer
CY2023Q4	STRW	Cumulative Number Of Properties CumulativeNumberOfProperties	98	integer
CY2024Q1	STRW	Cumulative Number Of Operational Beds CumulativeNumberOfOperationalBeds	12449	integer
CY2023Q4	STRW	Cumulative Number Of Operational Beds CumulativeNumberOfOperationalBeds	12201	integer
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	74070000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	89445000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	70893000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	71641000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	67945000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	229340000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	603334000	usd
CY2024Q1	STRW	Number Of Facilities Leased And Subleased To Thirdparties NumberOfFacilitiesLeasedAndSubleasedToThirdparties	3	integer
CY2023Q4	STRW	Number Of Facilities Leased And Subleased To Thirdparties NumberOfFacilitiesLeasedAndSubleasedToThirdparties	1	integer
CY2024Q1	STRW	Number Of Operational Beds NumberOfOperationalBeds	316	integer
CY2023Q4	STRW	Number Of Operational Beds NumberOfOperationalBeds	68	integer
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	52000	usd
CY2024Q1	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	109	integer
CY2023Q4	STRW	Cumulative Number Of Facilities CumulativeNumberOfFacilities	107	integer
CY2023Q4	STRW	Cumulative Number Of Properties CumulativeNumberOfProperties	98	integer
CY2024Q1	STRW	Cumulative Number Of Operational Beds CumulativeNumberOfOperationalBeds	12449	integer
CY2023Q4	STRW	Cumulative Number Of Operational Beds CumulativeNumberOfOperationalBeds	12201	integer
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	74070000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	89445000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	70893000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	71641000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	67945000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	603334000	usd
CY2024Q1	STRW	Number Of Facilities Leased And Subleased To Thirdparties NumberOfFacilitiesLeasedAndSubleasedToThirdparties	3	integer
CY2023Q4	STRW	Number Of Facilities Leased And Subleased To Thirdparties NumberOfFacilitiesLeasedAndSubleasedToThirdparties	1	integer
CY2024Q1	STRW	Number Of Operational Beds NumberOfOperationalBeds	316	integer
CY2023Q4	STRW	Number Of Operational Beds NumberOfOperationalBeds	68	integer
CY2023Q4	STRW	Number Of Facilities Leased And Subleased To Thirdparties NumberOfFacilitiesLeasedAndSubleasedToThirdparties	1	integer
CY2024Q1	STRW	Number Of Operational Beds NumberOfOperationalBeds	316	integer
CY2023Q4	STRW	Number Of Operational Beds NumberOfOperationalBeds	68	integer
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	192000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	99000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4413000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1542000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4413000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1542000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y1M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	550000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	744000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	754000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	764000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	468000	usd
CY2024Q1	STRW	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	1934000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	801000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4413000	usd
CY2024Q1	us-gaap	Payments For Rent PaymentsForRent	53000	usd
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	52000	usd
CY2023Q4	STRW	Number Of Facilities Leased And Subleased To Thirdparties NumberOfFacilitiesLeasedAndSubleasedToThirdparties	1	integer
CY2024Q1	STRW	Number Of Operational Beds NumberOfOperationalBeds	316	integer
CY2023Q4	STRW	Number Of Operational Beds NumberOfOperationalBeds	68	integer
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	192000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	99000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4413000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1542000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4413000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1542000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y1M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	550000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	744000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	754000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	764000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	468000	usd
CY2024Q1	STRW	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	1934000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5214000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	801000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4413000	usd
CY2024Q1	us-gaap	Payments For Rent PaymentsForRent	53000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	192000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	99000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4413000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1542000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4413000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1542000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y1M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	550000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	744000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	754000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	764000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	468000	usd
CY2024Q1	STRW	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	1934000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	801000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4413000	usd
CY2024Q1	us-gaap	Payments For Rent PaymentsForRent	53000	usd
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	52000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	96310000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	70455000	usd
CY2024Q1	STRW	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	230249000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	560351000	usd
CY2024Q1	STRW	Number Of Outstanding Credit Related Instrument NumberOfOutstandingCreditRelatedInstrument	41	integer
CY2023Q4	STRW	Number Of Outstanding Credit Related Instrument NumberOfOutstandingCreditRelatedInstrument	41	integer
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	550000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	744000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	754000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	764000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	468000	usd
CY2024Q1	STRW	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	1934000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5214000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	801000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4413000	usd
CY2024Q1	us-gaap	Payments For Rent PaymentsForRent	53000	usd
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	52000	usd
CY2024Q1	STRW	Notes Payable Gross NotesPayableGross	560351000	usd
CY2023Q4	STRW	Notes Payable Gross NotesPayableGross	539145000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1435000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2659000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	558916000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	536486000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	17138000	usd
CY2024Q1	STRW	Notes Payable Gross NotesPayableGross	560351000	usd
CY2023Q4	STRW	Notes Payable Gross NotesPayableGross	539145000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1435000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2659000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	558916000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	536486000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	17138000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	21404000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	124795000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	96310000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	70455000	usd
CY2024Q1	STRW	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	230249000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	560351000	usd
CY2024Q1	STRW	Number Of Outstanding Credit Related Instrument NumberOfOutstandingCreditRelatedInstrument	41	integer
CY2023Q4	STRW	Number Of Outstanding Credit Related Instrument NumberOfOutstandingCreditRelatedInstrument	41	integer
CY2024Q1	us-gaap	Interest Expense Other InterestExpenseOther	7732000	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	4808000	usd
CY2024Q1	STRW	Notes Payable Gross NotesPayableGross	560351000	usd
CY2023Q4	STRW	Notes Payable Gross NotesPayableGross	539145000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1435000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2659000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	558916000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	536486000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	17138000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	21404000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	124795000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	96310000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	70455000	usd
CY2024Q1	STRW	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	230249000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	560351000	usd
CY2024Q1	STRW	Number Of Outstanding Credit Related Instrument NumberOfOutstandingCreditRelatedInstrument	41	integer
CY2023Q4	STRW	Number Of Outstanding Credit Related Instrument NumberOfOutstandingCreditRelatedInstrument	41	integer
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	4808000	usd
CY2024Q1	STRW	Notes Payable Gross NotesPayableGross	560351000	usd
CY2023Q4	STRW	Notes Payable Gross NotesPayableGross	539145000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1435000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2659000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	558916000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	536486000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	17138000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	21404000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	124795000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	96310000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	70455000	usd
CY2024Q1	STRW	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	230249000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	560351000	usd
CY2024Q1	STRW	Number Of Outstanding Credit Related Instrument NumberOfOutstandingCreditRelatedInstrument	41	integer
CY2023Q4	STRW	Number Of Outstanding Credit Related Instrument NumberOfOutstandingCreditRelatedInstrument	41	integer
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	4808000	usd
CY2024Q1	STRW	Income Tax Description IncomeTaxDescription	U.S. federal income tax law requires that a REIT distribute annually at least 90% of its net taxable income, excluding net capital gains, and that it pays tax at regular corporate rates to the extent that it annually distributes less than 100% of its net taxable income, including net capital gains. In addition, a REIT is required to pay a 4% nondeductible excise tax on the amount, if any, by which the distributions that it makes in a calendar year are less than the sum of 85% of its ordinary income, 95% of its capital gain net income and 100% of its undistributed income from prior years
CY2023Q1	us-gaap	Proceeds From Rents Received ProceedsFromRentsReceived	11838000	usd
CY2024Q1	STRW	Income Tax Description IncomeTaxDescription	U.S. federal income tax law requires that a REIT distribute annually at least 90% of its net taxable income, excluding net capital gains, and that it pays tax at regular corporate rates to the extent that it annually distributes less than 100% of its net taxable income, including net capital gains. In addition, a REIT is required to pay a 4% nondeductible excise tax on the amount, if any, by which the distributions that it makes in a calendar year are less than the sum of 85% of its ordinary income, 95% of its capital gain net income and 100% of its undistributed income from prior years
CY2024Q1	us-gaap	Proceeds From Rents Received ProceedsFromRentsReceived	16714000	usd
CY2023Q1	us-gaap	Proceeds From Rents Received ProceedsFromRentsReceived	11838000	usd
CY2024Q1	STRW	Income Tax Description IncomeTaxDescription	U.S. federal income tax law requires that a REIT distribute annually at least 90% of its net taxable income, excluding net capital gains, and that it pays tax at regular corporate rates to the extent that it annually distributes less than 100% of its net taxable income, including net capital gains. In addition, a REIT is required to pay a 4% nondeductible excise tax on the amount, if any, by which the distributions that it makes in a calendar year are less than the sum of 85% of its ordinary income, 95% of its capital gain net income and 100% of its undistributed income from prior years
CY2024Q1	us-gaap	Proceeds From Rents Received ProceedsFromRentsReceived	16714000	usd
CY2023Q1	us-gaap	Proceeds From Rents Received ProceedsFromRentsReceived	11838000	usd
CY2024Q1	STRW	Income Tax Description IncomeTaxDescription	U.S. federal income tax law requires that a REIT distribute annually at least 90% of its net taxable income, excluding net capital gains, and that it pays tax at regular corporate rates to the extent that it annually distributes less than 100% of its net taxable income, including net capital gains. In addition, a REIT is required to pay a 4% nondeductible excise tax on the amount, if any, by which the distributions that it makes in a calendar year are less than the sum of 85% of its ordinary income, 95% of its capital gain net income and 100% of its undistributed income from prior years
CY2024Q1	us-gaap	Proceeds From Rents Received ProceedsFromRentsReceived	16714000	usd
CY2024Q1	STRW	Interest Expenses With Respect To Bonds InterestExpensesWithRespectToBonds	2284000	usd
CY2023Q1	STRW	Interest Expenses With Respect To Bonds InterestExpensesWithRespectToBonds	1214000	usd
CY2024Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	5631000	usd
CY2024Q1	STRW	Interest Expenses With Respect To Leases InterestExpensesWithRespectToLeases	47000	usd
CY2023Q1	STRW	Interest Expenses With Respect To Leases InterestExpensesWithRespectToLeases	19000	usd
CY2024Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	7962000	usd
CY2023Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	5091000	usd
CY2024Q1	STRW	Financing Income Expense FinancingIncomeExpense	230000	usd
CY2023Q1	STRW	Financing Income Expense FinancingIncomeExpense	283000	usd
CY2024Q1	us-gaap	Interest Expense Other InterestExpenseOther	7732000	usd
CY2024Q1	STRW	Interest Expenses With Respect To Bonds InterestExpensesWithRespectToBonds	2284000	usd
CY2023Q1	STRW	Interest Expenses With Respect To Bonds InterestExpensesWithRespectToBonds	1214000	usd
CY2024Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	5631000	usd
CY2023Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	3858000	usd
CY2024Q1	STRW	Interest Expenses With Respect To Leases InterestExpensesWithRespectToLeases	47000	usd
CY2023Q1	STRW	Interest Expenses With Respect To Leases InterestExpensesWithRespectToLeases	19000	usd
CY2024Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	7962000	usd
CY2023Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	5091000	usd
CY2024Q1	STRW	Financing Income Expense FinancingIncomeExpense	230000	usd
CY2023Q1	STRW	Financing Income Expense FinancingIncomeExpense	283000	usd
CY2024Q1	STRW	Interest Expenses With Respect To Bonds InterestExpensesWithRespectToBonds	2284000	usd
CY2024Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	5631000	usd
CY2023Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	3858000	usd
CY2024Q1	STRW	Interest Expenses With Respect To Leases InterestExpensesWithRespectToLeases	47000	usd
CY2023Q1	STRW	Interest Expenses With Respect To Leases InterestExpensesWithRespectToLeases	19000	usd
CY2024Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	7962000	usd
CY2023Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	5091000	usd
CY2024Q1	STRW	Financing Income Expense FinancingIncomeExpense	230000	usd
CY2023Q1	STRW	Financing Income Expense FinancingIncomeExpense	283000	usd
CY2024Q1	us-gaap	Interest Expense Other InterestExpenseOther	7732000	usd
CY2024Q1	STRW	Interest Expenses With Respect To Bonds InterestExpensesWithRespectToBonds	2284000	usd
CY2023Q1	STRW	Interest Expenses With Respect To Bonds InterestExpensesWithRespectToBonds	1214000	usd
CY2024Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	5631000	usd
CY2023Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	3858000	usd
CY2024Q1	STRW	Interest Expenses With Respect To Leases InterestExpensesWithRespectToLeases	47000	usd
CY2023Q1	STRW	Interest Expenses With Respect To Leases InterestExpensesWithRespectToLeases	19000	usd
CY2024Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	7962000	usd
CY2023Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	5091000	usd
CY2024Q1	STRW	Financing Income Expense FinancingIncomeExpense	230000	usd
CY2023Q1	STRW	Financing Income Expense FinancingIncomeExpense	283000	usd
CY2024Q1	us-gaap	Interest Expense Other InterestExpenseOther	7732000	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	4808000	usd

Files In Submission

Name	View Source	Status
0001493152-24-019017-index-headers.html	Edgar Link	pending
0001493152-24-019017-index.html	Edgar Link	pending
0001493152-24-019017.txt	Edgar Link	pending
0001493152-24-019017-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
0001493152-24-019017-index-headers.html	Edgar Link	pending
0001493152-24-019017-index.html	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
0001493152-24-019017.txt	Edgar Link	pending
R14.htm	Edgar Link	pending
0001493152-24-019017-xbrl.zip	Edgar Link	pending
R15.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R23.htm	Edgar Link	pending
form10-q.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R26.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
strw-20240331.xsd	Edgar Link	pending
strw-20240331_def.xml	Edgar Link	unprocessable
strw-20240331_lab.xml	Edgar Link	unprocessable
strw-20240331_pre.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
strw-20240331.xsd	Edgar Link	pending
strw-20240331_def.xml	Edgar Link	unprocessable
strw-20240331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
strw-20240331_cal.xml	Edgar Link	unprocessable
strw-20240331_pre.xml	Edgar Link	unprocessable
strw-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STRW
Strawberry Fields Reit Inc Stock $strw

2024 Q2 Form 10-Q Financial Statement

#000149315224019017 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STRW Strawberry Fields Reit Inc Stock $strw

2024 Q2 Form 10-Q Financial Statement

#000149315224019017 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STRW
Strawberry Fields Reit Inc Stock $strw